Reply to “The myth of hydroxychloroquine in the treatment of SARS-CoV-2 infection”
I respond to a recently-published TMJ Editorial Review,1 which commented on an article of mine entitled “The Curious Case of Hydroxychloroquine” published in Quadrant magazine (March 2024).2 I disagree with the reviewer’s points of view for the reasons presented here.